The head and neck cancer therapeutic landscape represents one of the most rapidly evolving sectors within global oncology, characterized by significant advancements in targeted therapies, immunotherapy protocols, and precision medicine approaches. This malignancy category encompasses cancers affecting the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, and salivary glands,...